DiaMedica Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-12.3M | $-12.3M | $22.0K | $1.6M |
| FY2022 | $-11.5M | $-11.6M | $81.0K | $1.5M |
| FY2023 | $-18.7M | $-18.8M | $24.0K | $1.7M |
| FY2024 | $-22.1M | $-22.1M | $25.0K | $2.1M |
| FY2025 | $-29.1M | $-29.1M | $40.0K | $3.8M |